Agilent Technologies Inc  

(Public, NYSE:A)   Watch this stock  
Find more results for A
+0.59 (1.08%)
After Hours: 55.29 -0.14 (-0.25%)
Apr 27, 4:11PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 54.83 - 55.51
52 week 40.26 - 55.51
Open 54.93
Vol / Avg. 1.53M/1.72M
Mkt cap 17.87B
P/E 35.67
Div/yield 0.13/0.95
EPS 1.55
Shares 322.30M
Beta 1.21
Inst. own 89%
May 22, 2017
Q2 2017 Agilent Technologies Inc Earnings Call - 4:30PM EDT - Add to calendar
May 22, 2017
Q2 2017 Agilent Technologies Inc Earnings Release - 4:00PM EDT - Add to calendar
Mar 16, 2017
Agilent Technologies Inc Annual Shareholders Meeting (Estimated)
Mar 15, 2017
Agilent Technologies Inc Annual Shareholders Meeting - Webcast
Mar 8, 2017
Agilent Technologies Inc at Cowen Health Care Conference
Feb 14, 2017
Q1 2017 Agilent Technologies Inc Earnings Call - Webcast
Feb 14, 2017
Q1 2017 Agilent Technologies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '17) 2016
Net profit margin 15.75% 10.99%
Operating margin 19.31% 14.64%
EBITD margin - 22.75%
Return on average assets 8.60% 6.05%
Return on average equity 15.78% 10.99%
Employees 12,600 -
CDP Score - -


5301 Stevens Creek Blvd
SANTA CLARA, CA 95051-7201
United States - Map
+1-408-3458886 (Phone)
+1-408-3458474 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Officers and directors

Michael R. McMullen President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Didier Hirsch Chief Financial Officer, Senior Vice President
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Tang Senior Vice President, General Counsel, Secretary
Age: 42
Bio & Compensation  - Reuters
Dominique P. Grau Senior Vice President - Human Resources
Age: 57
Bio & Compensation  - Reuters
Henrik Ancher-Jensen Senior Vice President, President - Order Fulfillment
Age: 51
Bio & Compensation  - Reuters
Mark Doak Senior Vice President, President - Agilent CrossLab Group
Age: 61
Bio & Compensation  - Reuters
Patrick K. Kaltenbach Senior Vice President, President - Life Sciences and Applied Markets Group
Age: 53
Bio & Compensation  - Reuters
Samraat Raha Senior Vice President - Strategy and Corporate Development
Bio & Compensation  - Reuters
Jacob Thaysen Senior Vice President, President - Diagnostics and Genomics Group
Age: 41
Bio & Compensation  - Reuters
Rodney Gonsalves Chief Accounting Officer, Vice President, Corporate Controller
Age: 51
Bio & Compensation  - Reuters